|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.62 USD | -0.82% |
|
-0.82% | -4.74% |
Jerusalem Pharmaceuticals Co. Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 39.65 million compared to USD 46.14 million a year ago.
Net income was USD 6.96 million compared to USD 7.17 million a year ago. Basic earnings per share was USD 0.386 compared to USD 0.399 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.74% | 6.52Cr | |
| +20.11% | 4.33TCr | |
| +27.64% | 2.24TCr | |
| +20.36% | 1.55TCr | |
| +19.13% | 1.45TCr | |
| +56.44% | 1.29TCr | |
| -0.05% | 678.76Cr | |
| -11.39% | 655.78Cr | |
| +17.73% | 587.1Cr | |
| -8.87% | 572.55Cr |
JERUSALEM PHARMACEUTICALS CO. LTD. 
